ART4 and glioblastoma: In glioblastoma, it has been documented that neuron-specific rabies virus glycoprotein (RVG) peptide-modified sEVs provide an efficient tissue-targeting delivery mechanism for the treatment of glioblastoma and Alzheimer’s disease (85, 86).